Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis
Background Tofacitinib (CP-690,550) is a novel oral Janus kinase inhibitor that is being investigated as a targeted immunomodulator and disease-modifying therapy for rheumatoid …..... Read More